Juvelook Hybrid Biostimulator: PDLLA + HA

Retail price: 169.00
Wholesale: 84.50 - 135.20
*Depending on quantity: 20% to 50% OFF

Juvelook Hybrid Biostimulator (1 Vial x 50mg) is an advanced Korean injectable combining 42.5mg PDLLA and 7.5mg Hyaluronic Acid. Designed for thin skin, tear troughs, and fine lines, it delivers immediate hydration while stimulating natural collagen production for long-lasting redensification, smooth skin texture, and pore refinement.

Get Exclusive Wholesale Rates

Quantity discounts
Quantity Discount Price
10-2920%135.20
30-9935%109.85
100-24940%101.40
250-49945%92.95
500-Unlimited50%84.50

Professional Wholesale Supply:
As a specialized wholesale distributor, we offer high-quality dermal fillers intended for professional application. By proceeding, you acknowledge that these solutions are designed for use by trained specialists to ensure optimal safety and results.

Description

Juvelook is an advanced hybrid biostimulator engineered for fine-line correction, dermal redensification, and periocular rejuvenation. Combining Poly D,L-Lactic Acid (PDLLA) with non-crosslinked Hyaluronic Acid (HA), this dual-action solution delivers immediate surface hydration alongside progressive, long-term collagen neo-synthesis. Designed with ultra-fine porous microparticles, Juvelook restores natural skin volume, refines skin texture, and smooths delicate areas (such as under-eye hollows and neck lines) without causing granulomas or over-volumization.

Key Product Benefits

  • Hybrid Dual Action: Delivers immediate hydration and subtle plumping via Hyaluronic Acid while PDLLA triggers natural type I collagen production.

  • Targeted Delicate Area Restoration: Formulated specifically for thin skin zones, including the periocular area (tear troughs, under-eye fine lines), neck, and forehead.

  • High Safety & Uniform Dispersion: Porous PDLLA micro-particles ensure smooth bio-integration, minimizing the risk of nodule formation or uneven texture.

  • Progressive & Long-Lasting Results: Sustained neocollagenesis yields skin tightening and textural refinement for up to 18–24 months post-treatment cycle.

  • Pore Refinement & Textural Repair: Effective in smoothing post-blemish marks, refining enlarged pores, and rebuilding compromised dermal matrix structures.

Target Treatment Areas

  • Periocular Region: Under-eye tear troughs, fine crow’s feet, and delicate lower lid tissue.

  • Face & Forehead: Superficial wrinkles, forehead lines, smile lines, and textural roughness.

  • Neck & Décolleté: Horizontal neck bands (tech-neck lines) and crepy chest tissue.

  • Post-Blemish Marks & Textural Unevenness: Targeted micro-application for surface texture remodeling.

Product Specifications

Feature Specification
Product Name Juvelook Hybrid Biostimulator
Active Composition PDLLA (Poly D,L-Lactic Acid) 42.5mg + Hyaluronic Acid 7.5mg
Total Weight per Vial 50mg / vial (Freeze-dried powder)
Formulation Type Hybrid Biostimulator & Dermal Matrix Regenerator
Packaging Layout 1 Vial x 50mg per box
Reconstitution Fluid 0.9% Sterile Saline Solution (plus optional Lidocaine)
Application Layer Intradermal / Superficial Subdermal (Micro-papular, Cannula, or Meso-gun)
Recommended Course 2 to 3 sessions spaced 4 weeks apart
Storage Parameters Store at room temperature (1°C to 30°C); keep dry and protected from direct sunlight

Primary Active Components

  • PDLLA (Poly D,L-Lactic Acid – 42.5mg): Biocompatible, biodegradable synthetic polymer featuring spherical, porous microparticles. It stimulates host fibroblasts to secrete new structural collagen over time.

  • Hyaluronic Acid (7.5mg): Un-crosslinked HA acts as a carrier vehicle that provides instant hydration, immediate post-application smoothness, and optimal micro-particle distribution.

Reconstitution & Application Protocols

  • Reconstitution Procedure: Add 5ml to 6ml of sterile physiological saline (0.9% NaCl) into the 50mg vial. Allow the solution to hydrate for at least 30 minutes (or use a mechanical shaker for rapid integration) prior to administration.

  • Administration Method: Administered intradermally or into the superficial dermal-subdermal junction using fine micro-needles (e.g., 30G–32G) or 27G/30G micro-cannulas.

  • Recommended Treatment Cycle: Perform 2 to 3 sessions spaced 4 weeks apart, with maintenance recommended after 12 to 18 months.

  • Post-Treatment Guidance: Lightly massage the treated area following protocol to ensure uniform dispersion. Advise patients to apply SPF 50+, avoid extreme thermal conditions (saunas, sunbeds) for 7 days, and maintain adequate systemic hydration.

Frequently Asked Questions (FAQ)

Q: Is Juvelook classified as a Biostimulator or a Hyaluronic Acid Filler?

A: Juvelook is a hybrid biostimulator. While it contains HA for immediate hydration, its primary function is long-term tissue regeneration and neocollagenesis driven by PDLLA.

Q: How does Juvelook differ from Lenisna?

A: Juvelook (50mg) features smaller particle sizes designed for superficial intradermal application and delicate zones (e.g., under-eyes, neck). Lenisna / Juvelook Volume (200mg) has larger particle sizes intended for deeper subdermal placement, deep fold correction, and structural body/facial volumization.

Q: Can Juvelook be safely used in the under-eye area?

A: Yes, Juvelook’s spherical porous PDLLA structure is specifically optimized for thin, delicate skin like the periocular zone, minimizing the risk of visible bumps or Tyndall effect.

⚠️ Disclaimer & Intellectual Property Notice

Technical names, packaging parameters, and active ingredient specifications serve strictly for accurate product identification and descriptive purposes in professional aesthetic contexts.

Trustpilot